Sector | Healthcare |
Industry | - |
Day Range | 36.62 | 37.00 |
52-Wk Range | - | - |
Last Close | - |
Mkt Cap (m) | - |
Dividend yield | - |
ISIN | US7170811035 |
Volume | 33,388,145.00 |
Exchange Venue | NYS |
Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.
Price/Earning | - |
Price/Book | - |
Price/Sales | - |
P/CF | - |
Rev Growth (3 year avg) | - |
EPS Growth (3 year avg) | - |
Operating Margin % | - |
Net Margin % | - |
Return on Equity | - |
Debt/Equity | - |
en 20/05/2020 |
en 31/12/2019 |
Please refer to the below issuer website for further documents.
USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Revenue (m) | 48,851.00 | 52,824.00 | 52,546.00 | 53,647.00 | 51,750.00 | - |
Operating Income (m) | 12,976.00 | 13,730.00 | 14,107.00 | 15,045.00 | 13,921.00 | - |
Net Income (m) | 6,960.00 | 7,215.00 | 21,308.00 | 11,153.00 | 16,273.00 | - |
Basic EPS | 1.13 | 1.18 | 3.57 | 1.90 | 2.92 | - |
Avg. Diluted Shares Outstanding (m) | 6,257.00 | 6,159.00 | 6,058.00 | 5,977.00 | 5,675.00 | - |
USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Current Assets (m) | 43,804.00 | 38,949.00 | 41,141.00 | 49,926.00 | 32,803.00 | - |
Non Current Assets (m) | 123,658.00 | 132,666.00 | 130,654.00 | 109,497.00 | 134,685.00 | - |
Total Assets (m) | 167,460.00 | 171,615.00 | 171,797.00 | 159,422.00 | 167,489.00 | - |
Current Liabilities (m) | 29,399.00 | 31,115.00 | 30,427.00 | 31,858.00 | 37,304.00 | - |
Total Liabilities (m) | - | - | - | - | - | - |
Total Equity (m) | 64,720.00 | 59,544.00 | 71,308.00 | 63,407.00 | 63,143.00 | - |
USD | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
Operating Cash Flows (m) | 14,512.00 | 15,901.00 | 16,470.00 | 15,827.00 | 12,588.00 | - |
Capital Expenditure (m) | -1,496.00 | -1,999.00 | -2,217.00 | -2,196.00 | -2,594.00 | - |